Albemarle (NYSE:ALB) reported Q1 EPS of $2.38, $0.75 better than the analyst estimate of $1.63. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Albemarle sees FY2022 EPS of $9.25-$12.25, versus the consensus of $6.22. Albemarle sees FY2022 revenue of $5.2-5.6 billion, versus the consensus of $4.4 billion.